VOYA Investment Management’s Turning Point Therapeutics, Inc. Common Stock TPTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-17,382
Closed -$1.31M 2999
2022
Q2
$1.31M Sell
17,382
-707
-4% -$31.4K ﹤0.01% 1274
2022
Q1
$486K Sell
18,089
-73
-0.4% -$2.45K ﹤0.01% 1936
2021
Q4
$866K Buy
18,162
+210
+1% +$9.39K ﹤0.01% 1640
2021
Q3
$1.19M Hold
17,952
﹤0.01% 1453
2021
Q2
$1.4M Buy
17,952
+1,506
+9% +$111K ﹤0.01% 1403
2021
Q1
$1.56M Buy
16,446
+722
+5% +$85.9K ﹤0.01% 1312
2020
Q4
$1.92M Buy
15,724
+4,420
+39% +$484K ﹤0.01% 1166
2020
Q3
$988K Buy
11,304
+1,687
+18% +$118K ﹤0.01% 1298
2020
Q2
$621K Sell
9,617
-4,204
-30% -$243K ﹤0.01% 1519
2020
Q1
$617K Buy
13,821
+303
+2% +$16.1K ﹤0.01% 1496
2019
Q4
$842K Buy
+13,518
New +$643K ﹤0.01% 1558

VOYA Investment Management's TPTX Position: Q3 2022 in Review

VOYA Investment Management sold out of Turning Point Therapeutics, Inc. Common Stock (TPTX) in Q3 2022, closing a stake of 17,382 shares — an estimated $1.31M sold.

VOYA Investment Management first reported a position in TPTX in Q4 2019 and held it in 11 quarters. The position peaked at $1.92M in Q4 2020. 0 funds tracked by Wall St. Rank hold TPTX as of Q3 2022.

  • VOYA Investment Management reported no remaining Turning Point Therapeutics, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
  • VOYA Investment Management sold 17,382 Turning Point Therapeutics, Inc. Common Stock shares in Q3 2022, an estimated $1.31M.
  • VOYA Investment Management first reported a position in Turning Point Therapeutics, Inc. Common Stock in Q4 2019 and held it in 11 quarters.
  • VOYA Investment Management's Turning Point Therapeutics, Inc. Common Stock position peaked at $1.92M in Q4 2020.
  • 0 funds tracked by Wall St. Rank held Turning Point Therapeutics, Inc. Common Stock as of Q3 2022.

Based on VOYA Investment Management's 13F filing for Q3 2022, filed 14 Nov 2022.